Organogenesis Holdings Inc.ORGONASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank89
3Y CAGR+27.4%
5Y CAGR+17.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+27.4%/yr
Annual compound
5Y CAGR
+17.5%/yr
Recent acceleration
Percentile
P89
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$83.32M+428.6%
2024$15.76M-56.3%
2023$36.03M-10.6%
2022$40.32M-53.7%
2021$87.00M+133.7%
2020$37.23M+288.6%
2019$-19.74M+57.9%
2018$-46.92M-2140.6%
2017$-2.09M-19.3%
2016$-1.75M-